期刊文献+

湿化高流量鼻导管通气全身麻醉下支撑喉镜手术后苏醒延迟1例分析

Delayed awakening after microlaryngeal surgery under general anesthesia by humidified high-flow nasal cannula: an analysis of 1 patient
下载PDF
导出
摘要 目的探讨湿化高流量鼻导管通气(HFNC)用于喉显微手术的安全性和可行性。方法回顾性分析1例湿化高流量鼻导管通气全身麻醉下支撑喉镜下行会厌囊肿切除术,出现明显二氧化碳潴留和苏醒延迟患者的病史及相关检查、麻醉过程、术后苏醒情况等。结果患者预充氧时间太短(仅1 min),窒息时间太长(达20 min)是造成二氧化碳蓄积,进而导致苏醒延迟的主要原因。结论HFNC可以延长安全窒息时间,可用于喉部手术、气管异物、气管狭窄等气道内手术,临床应当遵守HFNC专家共识的建议,规范操作,HFNC预充氧时间不能太短,长时间窒息可能导致二氧化碳潴留,明显的二氧化碳潴留对意识有一定的影响,临床应用中要加以重视。 Objective To investigate the safety and feasibility of high-flow nasal cannula oxygen therapy(HFNC)for laryngeal microsurgery.Methods A case of epiglottic cyst resection using HFNC under general anaesthesia was performed.The history and related examination,anesthesia course and postoperative recovery of patient with obvious carbon dioxide retention and delayed recovery were analyzed.Results The preoxygenation time was too short(only 1 min)and the suffocation time was too long(up to 20 min)in this case were the main reasons for the accumulation of carbon dioxide and delayed recovery.Conclusion HFNC can prolong the safe asphyxia time and can be used for intra airway procedures such as laryngeal surgery,tracheal foreign body,and tracheal stenosis.Operations should standardize and follow the recommendations of HFNC expert consensus.The pre-oxygenation time of HFNC should not be too short.Long time suffocation may lead to carbon dioxide retention that has a certain effect on consciousness.These should be emphasized in clinical applications.
作者 肖翠容 刘友坦 李平 XIAO Cui-rong;LIU You-tan;LI Ping(Department of Anesthesiology,Shenzhen Hospital,Southern Medical University,Shenzhen 518101,Guangdong,China;不详)
出处 《广东医学》 CAS 2021年第9期1085-1087,共3页 Guangdong Medical Journal
关键词 湿化高流量鼻导管通气 二氧化碳潴留 苏醒延迟 humidified high flow nasal cannula CO_(2) retention awakening delay
  • 相关文献

参考文献3

二级参考文献33

  • 1上官王宁,连庆泉,陈小玲,李军,Fang Gao Smith.顺式阿曲库铵对手术患儿的肌松作用[J].中华麻醉学杂志,2005,25(5):395-396. 被引量:18
  • 2邱郁薇,李士通.非去极化肌松药相互作用的机制及临床应用[J].国际麻醉学与复苏杂志,2007,28(3):250-252. 被引量:9
  • 3张象麟.药物临床信息参考[M].重庆:重庆出版社,2008:674-675.
  • 4De Ruiter J,Crawford MW.Dose-response relationship and infusion requirement of cisatracurium besylate in in-fants and children during nitrous oxide-narcotic anesthesia[J].Anesthesiology,2001,94 (5):790-792.
  • 5Kenaan CA,Estacio RL,Bikhazi GB.Pharmacodynamics and intubating conditions of cisatracurium in children during halothane and opioid anesthesia[J].Clinical anaesthesiology,2000,12 (3):1731.
  • 6Taivainen T,Meakin GH,Meretoja OA,et al.The safety and efficacy of cisatracurium 0.15mg∕kg during nitrous oxide-opioid anaesthesia in infants and children[J].Anaesthesia,2000,55 (11):1047-1051.
  • 7David FK,Virginia DS.Clinical Pharmacokinetics of Cisatracurium Besilate[J].Clin Pharmacokinet,1999,36 (1):27-40.
  • 8Adams WA,Mark-Senior J,Jones RS,et al.Cisatracurium in dogs with and without porto-systemic shunts[J].Vet-Anaesth-Analg,2006,33 (1):17-23.
  • 9卢慧勤,郭建荣.顺式阿曲库铵药代学和药效学研究进展[C].2008年第七次华东六省一市麻醉学学术会议暨浙江省麻醉学术年会论文汇编(上册),2008.
  • 10Melloni C,Devivo P,Launo C,et al.Cisatracurium versus vecuronium:A comparative,double blind,randomized,multicenter study in adult patients under propofol/ fentany/ N2O anesthesia[J].Minerva Anestesiol,2006,72(5):299-308.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部